bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.880
+0.220 (8.27%)
At close: Oct 14, 2025, 4:00 PM EDT
2.775
-0.105 (-3.65%)
After-hours: Oct 14, 2025, 7:59 PM EDT

bioAffinity Technologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
7.689.362.530--
Revenue Growth (YoY)
4.99%269.68%52627.44%---
Cost of Revenue
5.395.981.740--
Gross Profit
2.293.380.790--
Selling, General & Admin
9.959.946.792.481.070.99
Research & Development
1.831.781.721.521.141.61
Operating Expenses
12.3612.338.764.022.212.6
Operating Income
-10.06-8.95-7.97-4.01-2.21-2.6
Interest Expense
-0.07-0.09-0.04-2.53-1-0.38
Interest & Investment Income
0.010.020.120.0500
Other Non Operating Income (Expenses)
-1.520-0.03-1.87-3.36-
EBT Excluding Unusual Items
-11.65-9.03-7.92-8.36-6.56-2.99
Other Unusual Items
---0.210.24-4.28
Pretax Income
-11.65-9.03-7.92-8.15-6.32-7.27
Income Tax Expense
0.040.010.02000
Net Income
-11.69-9.04-7.94-8.15-6.33-7.27
Net Income to Common
-11.69-9.04-7.94-8.15-6.33-7.27
Shares Outstanding (Basic)
100000
Shares Outstanding (Diluted)
100000
Shares Change (YoY)
71.52%38.61%94.43%68.17%0.02%-
EPS (Basic)
-20.78-22.37-27.22-54.37-70.94-81.52
EPS (Diluted)
-20.78-22.37-27.22-54.37-70.94-81.52
Free Cash Flow
-7.75-7.34-6.06-4.29-2.05-2.21
Free Cash Flow Per Share
-13.78-18.17-20.79-28.61-22.98-24.79
Gross Margin
29.87%36.09%31.26%90.28%--
Operating Margin
-131.01%-95.64%-314.84%-83511.51%--
Profit Margin
-152.18%-96.56%-313.41%-169771.25%--
Free Cash Flow Margin
-100.89%-78.44%-239.32%-89336.50%--
EBITDA
-9.49-8.35-7.72-4-2.2-2.58
EBITDA Margin
-123.55%-89.17%----
D&A For EBITDA
0.570.610.250.0100.02
EBIT
-10.06-8.95-7.97-4.01-2.21-2.6
EBIT Margin
-131.01%-95.64%----
Advertising Expenses
-0.270.090.04--
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q